Literature DB >> 11516162

Bulk production and functional analyses of mouse CD55's native and deglycosylated active domains.

F Lin1, R M Immormino, M Shoham, M E Medof.   

Abstract

We report the use of methylotrophic yeast Pichia pastoris as a host to efficiently express complement control protein repeats (CCPs) 1-4 of mouse decay accelerating factor (DAF, CD55) as a soluble protein. With this system, the mouse DAF CCP1-4-active-domain-containing module linked to a 6x His tag at its C terminus was secreted into the culture supernatant at 15 mg/L after 24 h of induction with methanol. A mouse DAF CCP1-4 mutant protein in which its two potential N-glycosylation sites were deleted by changing Asn(187) and Asn(262) to Gln was also produced. Using Ni(2+)-immobilized agarose affinity chromatography, the recombinant mouse DAF modules with their 6x His tags could be one-step isolated to SDS-PAGE purity. Polyclonal antibody against native mouse DAF CCP1-4 was raised by immunizing NZW rabbits with the purified product. Measurements of the bioactivities of the wild-type and mutant mouse DAF proteins in C3b uptake assays showed no differences in regulatory activities in either the classical or the alternative pathways. With the use of the mutant DAF protein, small rod-shaped crystals were produced and preliminary data obtained. The production of large quantities of functional recombinant mouse DAF CCP1-4 modules and their antibody offers the opportunity to study DAF structure and DAF function in vivo. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516162     DOI: 10.1006/abbi.2001.2488

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.

Authors:  Yongning He; Feng Lin; Paul R Chipman; Carol M Bator; Timothy S Baker; Menachem Shoham; Richard J Kuhn; M Edward Medof; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

2.  Letter to the Editor: Resonance assignments of the central complement control protein module pair of human decay accelerating factor.

Authors:  Stanislava Uhrínová; Feng Lin; Du Usan Uhrín; M Edward Medof; Paul N Barlow
Journal:  J Biomol NMR       Date:  2002-06       Impact factor: 2.835

3.  Tissue distribution and functional analysis of Sushi domain-containing protein 4.

Authors:  Zhidan Tu; Mark Cohen; Hong Bu; Feng Lin
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

4.  Solution structure of a functionally active fragment of decay-accelerating factor.

Authors:  Stanislava Uhrinova; Feng Lin; Graeme Ball; Krystyna Bromek; Dusan Uhrin; M Edward Medof; Paul N Barlow
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

5.  Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.

Authors:  Zhidan Tu; Qing Li; Hong-Shiue Chou; Ching-Chuang Hsieh; Howard Meyerson; Marion G Peters; Hong Bu; John J Fung; Shiguang Qian; Lina Lu; Feng Lin
Journal:  Immunobiology       Date:  2010-08-19       Impact factor: 3.144

6.  Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: a possible option for treatment of myasthenia gravis.

Authors:  Chen Song; Zhikai Xu; Jianting Miao; Jiang Xu; Xingan Wu; Fanglin Zhang; Hong Lin; Zhuyi Li; Henry J Kaminski
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

7.  The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis.

Authors:  Qing Li; Kristine Nacion; Hong Bu; Feng Lin
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

8.  Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis.

Authors:  Fengqi An; Qing Li; Zhidan Tu; Hong Bu; Chi-Chao Chan; Rachel R Caspi; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.